Conclusions
myopia
MYOPIA
This randomized clinical trial found that RLRL is a novel and effective intervention for myopia prevention, with good user acceptability and a 54.1% reduction in incident myopia within 12 months for children with premyopia. Our findings have public health significance, especially for myopia prevention in countries with a high incidence of myopia. More studies are needed to understand the long-term efficacy and safety, optimal intervention dose, and potential underlying mechanisms of the RLRL intervention.